Reken, Germany

Holger York Toschka

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Unilever Patent Holdings B.v.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger York Toschka. Retrieved from https://idiyas.com/inventor/holger-york-toschka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 158(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Holger York Toschka: Innovator in Protein Immobilization

Introduction

Holger York Toschka is a notable inventor based in Reken, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of protein immobilization. With a total of two patents to his name, Toschka's work has implications for various applications in the industry.

Latest Patents

Toschka's latest patents include "Immobilized proteins with specific binding capacities and their use in" and "Process for immobilizing enzymes to the cell wall of a microbial cell." These innovations showcase his expertise in enhancing the functionality of proteins and enzymes, which can lead to advancements in various biotechnological processes.

Career Highlights

Holger York Toschka is currently associated with Unilever Patent Holdings B.V., where he continues to develop and refine his innovative ideas. His work at Unilever has allowed him to explore the practical applications of his research in a corporate setting.

Collaborations

Toschka has collaborated with notable colleagues, including Franciscus Maria Klis and Cornelis T Verrips. These partnerships have likely contributed to the depth and breadth of his research and patent developments.

Conclusion

Holger York Toschka stands out as an influential inventor in the field of protein immobilization. His patents reflect a commitment to advancing biotechnological applications, and his work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…